Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation
- PMID: 20200614
- PMCID: PMC2828568
- DOI: 10.1007/BF03091743
Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation
Abstract
Background/Methods. Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MFS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large fourgeneration Dutch family with MFS.Results. Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinical variability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time.Conclusion. MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.).
Keywords: Marfan Syndrome/genetics; Microfilament Proteins; Missense; Mutation; Netherlands.
Figures
Similar articles
-
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.Verh K Acad Geneeskd Belg. 2009;71(6):335-71. Verh K Acad Geneeskd Belg. 2009. PMID: 20232788 Review.
-
Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.Arch Intern Med. 2001 Nov 12;161(20):2447-54. doi: 10.1001/archinte.161.20.2447. Arch Intern Med. 2001. PMID: 11700157
-
Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.Am J Med Genet A. 2013 Sep;161A(9):2305-10. doi: 10.1002/ajmg.a.36044. Epub 2013 Jul 29. Am J Med Genet A. 2013. PMID: 23897642 Free PMC article.
-
Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.Hum Mutat. 2002 Sep;20(3):153-61. doi: 10.1002/humu.10113. Hum Mutat. 2002. PMID: 12203987 Review.
-
The roles of two novel FBN1 gene mutations in the genotype-phenotype correlations of Marfan syndrome and ectopia lentis patients with marfanoid habitus.Genet Test. 2008 Jun;12(2):325-30. doi: 10.1089/gte.2008.0002. Genet Test. 2008. PMID: 18471089
Cited by
-
Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.J Transl Med. 2016 May 4;14(1):115. doi: 10.1186/s12967-016-0870-4. J Transl Med. 2016. PMID: 27146836 Free PMC article.
-
Human stem cell models for Marfan syndrome: a brief overview of the rising star in disease modelling.Front Cell Dev Biol. 2025 Jan 3;12:1498669. doi: 10.3389/fcell.2024.1498669. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 39830211 Free PMC article. Review.
-
Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.PLoS One. 2012;7(9):e44639. doi: 10.1371/journal.pone.0044639. Epub 2012 Sep 11. PLoS One. 2012. PMID: 22984535 Free PMC article.
-
Mitral valve disease in Marfan syndrome and related disorders.J Cardiovasc Transl Res. 2011 Dec;4(6):741-7. doi: 10.1007/s12265-011-9314-y. Epub 2011 Aug 25. J Cardiovasc Transl Res. 2011. PMID: 21866385 Review.
-
The revised role of TGF-β in aortic aneurysms in Marfan syndrome.Neth Heart J. 2015 Feb;23(2):116-21. doi: 10.1007/s12471-014-0622-0. Neth Heart J. 2015. PMID: 25342281 Free PMC article.
References
-
- De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62:417–26. - PubMed
-
- De Backer J, Loeys B, Leroy B, Coucke P, Dietz H, De Paepe A. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome. Clin Genet. 2007;72:188–98. - PubMed
-
- Giusti B, Porciani MC, Brunelli T, Evangelisti L, Fedi S, Gensini GF, et al. Phenotypic variability of cardiovascular manifestations in Marfan syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J. 2003;24:2038–45. - PubMed
-
- Hutchinson S, Furger A, Halliday D, Judge DP, Jefferson A, Dietz HC, et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum Mol Genet. 2003;12:2269–76. - PubMed
LinkOut - more resources
Full Text Sources